眼眶与泪道手术中的术中影像导航:美国眼科学会报告
本文综述术中影像导航(IIG)在眼眶与泪道手术中的疗效与安全性。检索PubMed至2023年11月,纳入32项研究,仅2项为II级证据、30项为III级,无I级证据。少量对比研究提示眼眶骨折修复中使用IIG可能改善结局,但各研究存在多种局限;泪道手术、肿瘤和减压手术缺乏高质量对比研究,未报告IIG相关并发症,也未分析成本节约。
要点
- 眼眶骨折修复的两项II级研究提示IIG组结局可能更好,但均存在多种局限。
- 泪道手术、肿瘤和减压手术缺乏高质量对比研究。
- 未报告IIG相关并发症,也未分析成本节约。
核心结论
- 少量对比研究提示眼眶骨折修复中使用IIG可改善结局,但每项研究均存在多种局限。
- 泪道手术、肿瘤性疾病或减压手术尚无高质量对比研究。
- 未发现归因于IIG使用的并发症,也未分析IIG的成本节约。
研究设计与样本
- 美国眼科学会(American Academy of Ophthalmology)组织专家小组,检索PubMed数据库至2023年11月,纳入评估任何影像导航系统在眼眶与泪道手术中应用的英文原创研究,要求至少包含5例患者。
- 检索共识别524篇文章,小组选出94篇进行全文分析,最终32项研究符合纳入标准;方法学家将2项研究定为II级证据,30项定为III级,无研究达到I级证据标准。
主要发现
- 报告的手术类型包括:骨折修复(n=14)、肿瘤和浸润性病变活检或切除(n=6)、Graves眼病眼眶减压(n=3)、泪囊鼻腔吻合术(n=1)以及混合病因和手术(n=8)。
- 有4项研究使用了不止一种IIG系统。
- 一项符合II级证据标准的研究比较了使用IIG(n=29)与不使用IIG(n=29)的眼眶骨折修复结局,IIG组报告了边缘性更好的结局:复视2% vs 10%(P=0.039),眼球内陷3% vs 10%(P=0.065)。
- 另一项II级研究比较了使用导航(n=20)与不使用导航(n=20)的骨折修复,导航组测得的平均体积减少为3.82 cm3 vs 3.33 cm3(P=0.02),导航组测得的眼球内陷减少更多,为0.72 mm(P=0.001)。
- 其余30篇评估文章虽未达到II级标准,但均声称IIG有益;未报告并发症。
关键数值与推荐
- II级证据研究:使用IIG(n=29)与不使用IIG(n=29)的眼眶骨折修复比较,复视2% vs 10%(P=0.039),眼球内陷3% vs 10%(P=0.065)。
- II级证据研究:使用导航(n=20)与不使用导航(n=20)的骨折修复比较,平均体积减少3.82 cm3 vs 3.33 cm3(P=0.02),眼球内陷减少0.72 mm(P=0.001)。
- 证据等级:2项研究为II级,30项为III级,无I级证据。
临床怎么用
- 原文未据此给出推荐。
局限性
- 无研究达到I级证据标准。
- 每项对比研究均存在多种局限。
- 泪道手术、肿瘤性疾病或减压手术尚无高质量对比研究。
- IIG的成本节约尚未分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To review the efficacy and safety of the use of intraoperative image guidance (IIG) in orbital and lacrimal surgery. METHODS: A literature search of the PubMed database was last conducted in November 2023 for English-language original research that assessed the use of any image guidance system in orbital and lacrimal surgery that included at least 5 patients. The search identified 524 articles; 94 were selected for full-text analysis by the panel. A total of 32 studies met inclusion criteria. The panel methodologist assigned a level II rating to 2 studies and a level III rating to 30 studies. No study met the criteria for level I evidence. RESULTS: Procedures reported on were as follows: fracture repair (n = 14), neoplasm and infiltrate biopsy or excision (n = 6), orbital decompression for Graves ophthalmopathy (n = 3), dacryocystorhinostomy (n = 1), and mixed etiology and procedures (n = 8). Four studies used more than one IIG system. One study that met level II evidence criteria compared the outcomes of orbital fracture repair with IIG (n = 29) and without IIG (n = 29). Borderline better outcomes were reported in the IIG group: 2% versus 10% with diplopia (P = 0.039) and 3% versus 10% with enophthalmos (P = 0.065). The other level II study compared the repair of fractures with navigation (n = 20) and without (n = 20). The group in which navigation was used had a measured mean volume reduction of 3.82 cm3 compared with 3.33 cm3 (P = 0.02), and there was a greater measured reduction in enophthalmos in the navigation group of 0.72 mm (P = 0.001). Although the remaining 30 assessed articles failed to meet level II criteria, all alleged a benefit from IIG. No complications were reported. CONCLUSIONS: A small number of comparative studies suggest that there are improved outcomes when IIG is used in orbital fracture repair, but each study suffers from various limitations. No high-quality comparative studies exist for the management of lacrimal surgery, neoplastic disease, or decompression. Complications attributable to the use of IIG have not been identified, and IIG has not been analyzed for cost savings. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
引用
- McCulley TJ, Aakalu VK, Foster JA, et al. Intraoperative Image Guidance in Orbital and Lacrimal Surgery: A Report by the American Academy of Ophthalmology. Ophthalmology. 2024. PMID: 38912980. doi:10.1016/j.ophtha.2024.05.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。